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Glial cells comprise over 70% of the central nervous system cells and exhibit diverse 
functions including regulation of synaptic transmission, neuron protection/repair, maintenance of 
neuronal metabolism, and are implicated in the development of persistent neuropathic pain. In 
addition, a perturbation in the concentration of intracellular reactive oxygen species (ROS) and 
reactive nitrogen species (RNS) has likewise been associated with the development of a chronic 
pain state. This perturbation in ROS and RNS creates an environment of oxidative stress. 
However, the mechanism by which the pain signal transmission is modulated, and the roles ROS 
play in the perpetuation of the pain state are poorly understood processes. Although treatments 
using electrical stimulation (ES) have been shown to be effective in providing clinical pain relief, 
their mechanism of action is likewise poorly understood.  Traditional explanations propose that 
the applied electric field is affecting a specific population of neurons; however, it has been 
previously demonstrated in vivo that ES of rat neuronal tissue modulates the genes expressed in 
the surrounding glial cells.  Thus experiments have been designed to examine the potential effect 
of ES on ROS generation, RNS generation, and the gene expression of cultured Rattus 
norvegicus C6 glioma cells. This work has led to the development of a non-animal model system 
to evaluate the role(s) of glial cells. 
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CHAPTER I: INTRODUCTION 
The initiation, propagation, and perception of acute pain has been traditionally described 
in terms of the excitation of neuronal transmission pathways (Verkhratsky & Kirchhoff, 2007a).  
Although these pathways represent an integral process responsible for the organism’s perception 
of pain, they are unable to adequately explain the mechanism by which acute pain develops into 
chronic pain. It has been demonstrated that, in response to injury, neurons and glial cells sustain 
nociceptive signals via a variety of neurotransmitters, cytokines, and neuropeptides (Salvemini et 
al., 2011).  The initiating event in these signaling processes was reported by Grace et al. to 
involve the production of reactive oxygen species (ROS) and reactive nitrogen species (RNS) by 
both enzymatic and non-enzymatic processes (Matés et al., 2006; Salvemini et al., 2011; Grace et 
al., 2016).  The production of ROS and RNS results in hypersensitivity of neurons by altering the 
neuronal and biochemical processing within the synapses. When the neurons become sensitized, 
the acute nociceptive signals can persist initiating a chronic pain state (Grace et al., 2016). A 
recent explanation of this progression from acute to chronic pain implicates the activation of glial 
cells adjacent to the site of injury or inflammation in addition to sensitization of neurons (Kung 
et al., 2013).  In a healthy individual, glial cells function as housekeeping cells for neurons; 
however, once activated the glia will undertake an immunoresponsive role characterized by the 
release of chemical signals such as cytokines and chemokines that induce neuronal 
hyperexcitability, necrosis, and inflammation (Verkhratsky & Kettenmann, 1996).  This process 
would seem to exacerbate the symptomology of the chronic pain state, but it has been shown that 
the activated glia also release anti-inflammatory modulators indicative of a neuroprotective role 
(Milligan & Watkins, 2009).  Mechanistically speaking this process is very poorly understood 
and in need of description. Our collaborators at Millennium Pain Center (MPC; Bloomington, 
2 
 
IL) have previously performed a study that indicated chronic back pain can be attenuated via the 
application of electrical stimulation (ES) (Tiede et al., 2013). Other clinical reports indicate a 
similar effect of ES in alleviating chronic pain in humans (Sdrulla et al., 2018). In a separate 
study the chronic pain attenuation by ES seen in the rodent model was attributed to the 
modulation of gene expression for genes associated with nociceptive regulatory pathways 
(Vallejo et al., 2016).  These results, taken in conjunction with the reports of neuroprotective 
activity in glial cells, suggest that pain relief in response to electrical stimulation is potentially 
due, in part, to the differential expression of genes in the activated glial cells.  To investigate this 
in an animal cell culture system, in collaboration with MPC, experiments were designed to 
measure axenic glial cell gene expression, with or without the presence of the neurotransmitter 
glutamate, for a panel of genes reported to be associated with either oxidative stress or glial 
activation. Further, the production of reactive oxygen species by the glial cells, with or without 
the presence of the neurotransmitter glutamate, was also studied utilizing two fluorescent probes 
sensitive to the presence of superoxide radical (a potent ROS) and nitric oxide radical (RNS) 
species.   
Glutamate is an excitatory neurotransmitter which acts as a neuronal-glial signal 
activating glial cells via one of three types of glutamate receptors (Verkhratsky & Kirchhoff, 
2007b). Kainite, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, and N-methyl-D-
aspartic acid - type glutamate receptors are ionophore channels that, in the presence of glutamate, 
allow Ca2+ levels to change.  This glutamate signaling results in release of Ca2+ from the 
endoplasmic reticulum into the cytoplasm and propagation of an interglial Ca2+ wave.  This Ca2+ 
signal will activate NO synthase producing RNS in addition to propagating through gap 
junctions to adjacent glia or neurons (Verkhratsky & Kirchhoff, 2007b; Grace et al., 2016).  
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Additionally, gliotransmitters such as taurine and D-serine can also be released in response to 
changes in cytosolic Ca2+ (Verkhratsky & Kettenmann, 1996). Also, glutamate is reported to 
induce the production of ROS thereby resulting in oxidative stress (Liu et al., 2009). Taurine, in 
contrast, has been reported to elicit protective effects against ROS, and inflammation associated 
with oxidative stress (Niu et al., 2018). Given these various mechanisms reported to be involved 
with pain signaling and the clinical reports of ES attenuating pain, a series of experiments were 
conducted to 1) grow axenic glial cells in culture 2) measure changes in glial gene expression in 
response to glutamate with and without ES and 3) measure the production of glial ROS and RNS 





CHAPTER II: MATERIALS AND METHODS 
Glutamate – Glutamate was obtained from Sigma Aldrich (St. Louis, MO) and used as 
provided, at biologically relevant concentrations to stress the cultured glioma cells. It was first 
dissolved in H2O preparing a 100 mM stock solution.  This solution was loaded into a syringe 
and filter sterilized with a MILLEX® GP 0.22 μm syringe driven filter unit from Millipore 
(Cork, Ireland).   
Cell Culture – Axenic Rattus norvegicus C6 glioma cells (ATCC CCL-107) were grown 
in sterile 6-well plates using high glucose Dulbecco’s Modified Eagle’s Medium (incomplete 
DMEM) (Sigma Life Sciences D6429; St. Louis, MO) supplemented with 15% (v/v) horse 
serum (ATCC; Manassas, VA) and 5% (v/v) heat treated fetal bovine serum (GIBCO; Waltham, 
MA) designated as ‘complete medium’ (Cookson et al., 1995).  Cells were grown at 37 °C under 
a 5% CO2 atmosphere in the presence of an open vessel of H2O to maintain relative humidity.  
To transfer the adherent cells, trypsin (Sigma Life Sciences T4049; St. Louis, MO) was used to 
release cells from the bottom of the plate in accordance with the manufacturer’s instructions. The 
trypsin was subsequently neutralized upon addition of complete medium by the α-1 antitrypsin 
present from the serum supplementation of the complete DMEM.  This cell preparation was then 
centrifuged (Labnet Hermle Z 400K) at 2000 rpm for 10 minutes at 7°C. The supernatant was 
discarded and the resultant cell pellet was re-suspended in complete DMEM and plated as 
required.  Large cultures of cells were maintained in CELLSTAR® TC sterile 6-well plates 
(Greiner Bio-one).  For experimentation, cells were harvested, as previously described, re-
suspended in complete DMEM, and applied to tissue culture treated sterile 96-well cell culture 
plates (Falcon®) in a total volume of 100 µL per well.  Experiments began when the cells in the 
96-well plates were deemed confluent.  All cell culturing was performed in a UV sterilized hood 
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(Thermo Electron Corporation Forma Class II Biological Safety Cabinet) for maintaining sterile 
conditions. Surfaces contacted within the hood were treated with 70% ethanol solution to 
disinfect these surfaces.   
MTT Cell Viability Assay – The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) assay was utilized as described in the literature with slight modifications to 
assess glioma cell viability (Cookson et al., 1995).  MTT incubation occurred at room 
temperature for a duration of 45 minutes.  Absorbance was measured at 595 nm using a Bio-Rad 
iMark Microplate Reader. The experimental groups were conducted in quadruplicate and results 
reported as a mean ± standard deviation. This value was corrected by subtracting the average 
absorbance value of four medium only (negative control) wells. These assays were carried out in 
96 well plates in which the complete DMEM was replaced with incomplete DMEM diluted 1:10 
with filter sterilized saline.    
Light Microscopy – Visual assessment of the morphology and distribution of the glioma 
cells was performed using an inverted light microscope (JENCO USA) under 40x magnification. 
Images were captured with an Asus ZOOM3 digital camera.    
Fluorescent Probe Assays – Mitosox Red Superoxide indicator (Invitrogen), an analog 
of dihydroethidium, was prepared according to manufacturer’s instruction and implemented with 
a modification of the manufacturer’s directions.  This probe was utilized to assess the presence of 
superoxide radical species (Robinson et al., 2006).  Another probe, 2’-7’-dichlorofluorescin 
diacetate (DAF-FM), obtained from EDM Millipore Corp., was prepared according to 
manufacturer’s instructions and implemented with a modified procedure of the manufacturer’s 
directions.  DAF-FM is employed to assess the presence of nitric oxide radical species (Tjalkens 
et al., 2011).  For these assays, the medium was changed to a Modified Dulbecco’s Modified 
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Eagle’s Medium (MDMEM) made in house as shown in Appendix A.  As the name suggests, 
this medium is of similar composition as DMEM, but lacks the phenol red pH indicator, and did 
not contain sera as the experiments, utilizing this medium, were short in duration. This medium 
was sterilized in a CORNING® 250 mL filter system with a 0.22 μm cellulose acetate, low 
protein binding membrane (Sigma Aldrich; St. Louis, MO). Cells were incubated with the 
fluorescent probes with and without glutamate at 37°C for 1 hour.  Fluorescence measurements 
were collected utilizing a Thermo Electron Corporation Fluoroskan Ascent FL microplate 
fluorimeter at appropriate excitation and emission wavelengths depending on the probe. 
Fluorescent signals of Mitosox Red wells were assessed by a 544/590 nm excitation/emission 
couple.  Fluorescent signals of DAF-FM wells were assessed by a 485/538 nm 
excitation/emission couple. Data were collected in quadruplicate and Grubb’s tested (Grubbs, 
1950) to eliminate outlier signals. The average signal of the no cell control was then subtracted 
from each signal to correct for background fluorescence. The corrected signals were then 
averaged and subsequently normalized by dividing by the corrected average signal of the no 
treatment (e.g. no ES and/or no glutamate) glioma cells, but with the fluorescent probe. By doing 
these corrections and normalization a comparison can be made of the effect of ES and/or 
glutamate on the cells’ ROS and RNS probe signal relative to the ROS and RNS probe signal of 
a no treatment cell population without these perturbations. Fluorescent data were collected as a 
function of time. 
Electrical Stimulation – The electrical stimulation (ES) was accomplished using four 
concentric bipolar electrodes (FHC Microelectrodes; Bowdoin, ME) arranged in parallel, a 
current isolator (WPI A365; Sarasota, FL), and an arbitrary waveform generator (Siglent 
SDG1025; Shenzen, China). ES was applied at 50 Hz for 30 minutes using one of seven different 
7 
 
waveforms: cathodic (monophasic) or anodic (monophasic) (50 μsec pulse width), biphasic 
symmetric (SymBi) (50 μsec pulse width), biphasic asymmetric 1-2 (AsymBi 1-2) (50 μsec 
cathodic pulse width and 100 μsec anodic pulse width), biphasic asymmetric 2-1 (AsymBi 2-1) 
(50 μsec cathodic pulse width and 25 μsec anodic pulse width), and passively balanced cathodic 
(Cathodic PR) or anodic (Anodic PR) (60 μsec pulse width). Artistic representations of each of 
the waveforms are depicted in Figure 1.  The C6 glial cells (ATCC) were grown in 96-well plates 
with 100 μL complete DMEM medium per well. Two hours prior to stimulation, the medium 
was changed to high glucose DMEM with no sera (incomplete DMEM). A custom simulation 
apparatus, pictured in Figures 2 and 3, houses the concentric bipolar electrodes, and situates 
them in an appropriate orientation such that the electrode tip is submerged in the medium, but 
elevated above the bottom of the plate.  A post stimulation incubation was carried out for two 
hours at 37°C in 5% CO2 atmosphere.  Four replicate wells for each treatment condition then 
underwent RNA extraction using Tri-Reagent (Sigma Aldrich; St. Louis, MO) following 
manufacturer’s instructions. The four replicate wells were pooled during this extraction creating 
a single sample with sufficient RNA for analysis.  Twelve replicate wells were thus pooled into 
three samples giving an n=3 for each condition.  An example plate set-up is depicted in Figure 4.  
For each experiment two 96-well plates were seeded using a single pool of glioma cells in 
complete DMEM. One plate had no glutamate addition while another plate, seeded using the 
same cell pool, and also contained an additional 10 mM glutamate.  Additionally, each plate had 
four wells of cells designated for MTT cell viability assay. Cells were added to plates a 
minimum of 12 hours before the experiments were conducted to allow cells to adhere and spread 
to indicate normal glial cell morphology.  ES was done at room temperature in ambient 
atmosphere for 30 minutes with the 4 replicate wells to be pooled treated simultaneously.  
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Figure 1: Waveform representations. Balanced waveforms: symmetric biphasic*, anodic 
PR*, cathodic PR* (Top row; left to right). Unbalanced waveforms: anodic monophasic, 
cathodic monophasic*, asymmetric biphasic 2-1, and asymmetric biphasic 1-2 (Bottom row; left 
to right). *Waveforms used clinically (Tiede et al., 2013). 
   
Figure 2: Digital representation of the electrode holder (right) and stimulation apparatus 
(left).  The grooves in the apparatus guide the holder into an ideal position for stimulating any 



























Figure 3: Electrical stimulation example. Concentric bipolar electrodes housed within the 
electrode guide stimulating row 3 on of a 96-well plate. The four electrodes are pictured with 
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Figure 4: Example plate set up for ES experiments. RNA extracted from rows A-D are 
pooled for each condition, giving 3 total samples from 12 wells. For columns 7 and 8, the 
complete DMEM was replaced with incomplete DMEM 1:10 diluted in sterile saline prior to 
MTT analysis.  
Quantitative Polymerase Chain Reaction (QPCR) – After the post-stimulation 
incubation, the incomplete DMEM was removed and the glioma cell RNA extracted using Tri-
Reagent (Sigma Aldrich; St. Louis, MO) following the manufacturer’s instructions.  The isolated 
RNA samples were stored in 75% ethanol at -80°C. To remove any contaminating DNA or 
protein, the RNA was then processed using a GeneJET RNA Cleanup and Concentration 
Microkit obtained from ThermoFisher Scientific (Waltham, MA) and used in accordance with 
the manufacturer’s instructions.  An MJ Instruments Peltier Thermocycler 200 (Reno, NV) was 
used to transcribe the RNA sequences to cDNA.  Agilent AriaMx Real-Time PCR system (Santa 
Clara, CA) and a panel of DNA primers were then utilized to amplify and quantitate the cDNA 
sequences of selected genes. Expression data were normalized using the house-keeping gene 
GAPDH (Mori et al., 2008).  Comparison of normalized gene expression post treatment to 
unstimulated control glioma cells yielded differential expression attributable to ES alone, 








GAPDH: (Glyceraldehyde 3-phosphate dehydrogenase; enzyme in 
glycolysis pathway) 
(Mori, et al., 2008) 
GFAP: (Glial Fibrillary Acidic Protein; intermediate filament protein 
involved in communication and cell proliferation) 
(Weinstein, 1991) 
GSR: (Glutathione-disulfide (GSSG) Reductase; regenerates GSSG for 
resisting oxidative stress) 
(Deponte, 2013) 
SLC7A11: (cystine/glutamate transporter) (Bridges et al., 2012) 
BAG3: (involved in chaperone-assisted selective autophagy) (Arndt et al., 2010) 
HMOX1: (Heme Oxygenase, degrades heme producing CO in response to 
oxidative stress) 
(Loboda et al., 2016) 
MT2A: (Metallothionein-2; antioxidant protects against hydroxyl free 
radicals) 
(Ling et al., 2016) 
S100a4: (Calcium binding protein functions in motility, invasion, and 
tubulin polymerization) 
(Helfman et al., 2005) 
GS: (Glutamine Synthetase; converts glutamate to glutamine in response 
to elevated glutamate levels) 




CHAPTER III: RESULTS AND DISCUSSION 
MTT Assay Results – Due to the adherent behavior of this cell type there were initially 
concerns about the cells clumping together hindering the ability to evenly divide the cells into 
sub-cultures. To see if this was going to prove problematic, the MTT cell viability assay was 
used to establish whether or not aliquots of a single cell pool, delivered via an 8 channel 
pipettman, yielded sub-cultures in a reproducible fashion. The experiment began with a single, 
confluent well of glioma cells from a 6-well plate of cell. This population was trypsinized as 
previously described and then suspended in complete DMEM creating a single pool of cells. 
Aliquots ranging from 0-100 μL were seeded, in replicates of four, into a 96-well plate.  
Complete DMEM was then added to the wells such that each well had a final volume of 100 µL 
of medium. Plates were then incubated for 24 hrs. Next, the MTT cell viability assay was 
performed on the plate.  The absorbance at 595 nm of the four replicates was averaged and then 
corrected by subtracting the average absorbance of the no cell (medium only) control yielding 
the data plotted in Figure 5.  These data cleanly show that the glioma cells can be delivered with 
reproducibility and that the consistency of the MTT value from experiment to experiment is a 





 Figure 5: Results (mean ± SD; n = 4) from the serial dilution of a glial cell pool 
experiment. Data are shown by plotting the corrected A595nm per 45 minutes value as a function 
of volume of cell pool added to the well (with the volume of complete DMEM also added to 
yield a final volume of 100 µL; for example, if 20 µL of cell pool was seeded then 80 µL of 
medium was also added). 
 
The linear regression analysis of these data indicate that the absorbance at 595 nm 
responds linearly in comparison to the cell pool volume aliquots under the conditions tested.  
This result suggests that the pipette and operator are capable of populating 96-well plates with 
reproducible sub-cultures of glioma cells. Light microscopy images taken of this experiment are 
depicted in Figure 6 below and suggest a similar conclusion. 
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Figure 6: Light microscopy images (40x) of dilution experiment. Volumes aliquoted were 
10 μL (top left), 20 μL (top right), and 50 μL (bottom). 
 
Use of Light Microscopy to Asses Cells Exposed to Electrical Stimulation – Cells that 
are exposed to electrical fields of appropriate strength can be destroyed by electricity.  If the cell 
populations are greatly decreased by the ES parameters utilized during these experiments, 
differences in RNA expression levels between the experimental group and control group, that 
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received no ES, could be attributed to a difference in the population. To establish that the 
parameters of the electrical field applied during these experiments were not killing large swaths 
of the cells, light microscopy was used to visualize the cell population before and after ES.  
Some representative images are presented in Figure 7.  It can be seen that our ES waveform 
parameters cause very little change to cell morphology or distribution of cells on the plate.   
 
 Figure 7: Light microscopy images (40x) of the same cell population before cathodic PR 
ES (left) and after ES (right). 
Quantitative Polymerase Chain Reaction (QPCR) Results – The relative gene 
expression data gleaned from the QPCR analysis is overwhelming when represented on a single 
graph so the data for each gene were separated into three graphs.  For each gene, the first graph 
(I) compares the normalized gene expression of a cell population exposed to ES to the 
normalized gene expression of a replicate cell population that received no ES. For the first graph 
of each gene, the shaded exclusionary zone encompasses the mean ± SD of all of the 
unstimulated control populations (n = 3) for all the waveforms.  Relative gene expression levels 
falling outside the shaded region on these graphs will be interpreted as alterations in gene 
expression attributable to the ES waveform alone.  The second graph (II) is a comparison of 
16 
 
normalized gene expression of cells in the presence of 10 mM glutamate (n = 3) to the 
normalized gene expression of cells with ES and 10 mM glutamate added (n = 3). For the second 
graph of each gene, the shaded exclusionary zone encompasses the mean ± SD of all of the 
unstimulated control populations in the presence of glutamate for all the waveforms.  Relative 
gene expression levels falling outside the shaded region on these graphs will be interpreted as 
alterations in gene expression attributable to the effect of ES in the presence of added glutamate. 
The third graph (III) compares the normalized gene expression of cells with ES and with the 
addition of 10 mM glutamate (n = 3) to the normalized gene expression of cells with ES and no 
glutamate added (n = 3).  Relative gene expression levels falling outside the shaded region on 
these graphs are different than the mean and standard deviation of both the no ES and no ES with 
10 mM glutamate added and will be interpreted as alterations in gene expression attributable ES 
alone or ES with the addition of 10 mM glutamate. Note: the no ES control groups’ normalized 
expression levels, which delineate the grey region, are omitted in the interest of clarity on the 
third graphs for each gene. 
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BAG3 Results (I) – With no glutamate added the GAPDH normalized BAG3 expression 
with and without the 7 waveforms of ES are shown in Figure 8.  The anodic PR waveform 
results in an increase of approximately 30% in the normalized expression level of this gene 
relative to the no ES control normalized expression levels. All other groups fall within the mean 
and standard deviation of the control groups. 
 
Figure 8: Comparison of BAG3 normalized gene expression with the 7 ES waveforms to 





































































































Cathodic Anodic Sym Bi Asym Bi 2-1 Asym Bi 1-2 Anodic PR Cathodic PR 
18 
 
BAG3 Results (II) – The normalized BAG3 expression in the presence of added 
glutamate with and without ES is shown in Figure 9.  When added glutamate is present, the 
anodic monophasic waveform results in an increase by approximately 10% in the normalized 
expression level of this gene relative to the normalized expression level of the no ES control. All 
other groups fall within the mean and standard deviation of the control groups. 
 
Figure 9: Comparison of BAG3 normalized gene expression with the 7 ES waveforms 
and glutamate to the BAG3 normalized gene expression with only glutamate. Values are mean ± 
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BAG3 Results (III) – The normalized BAG3 expression with and without added 
glutamate in the presence of the 7 waveforms of ES is shown in Figure 10.  The anodic PR 
waveform, in the absence of added glutamate, results in an increase by approximately 20% in the 
normalized expression level of this gene relative to the no ES control groups’ normalized 
expression levels. However, application of ES and glutamate appears to return normalized 
expression to control levels. The anodic monophasic waveform, in the presence of added 
glutamate, results in an increase by approximately 10% in the normalized expression level of this 
gene relative to the no ES control groups’ normalized expression levels. All other groups fall 
within the mean and standard deviation of the control groups. 
 
Figure 10: Comparison of BAG3 normalized gene expression with the 7 ES waveforms 
and the 7 ES waveforms with glutamate to the BAG3 normalized gene expression control groups 
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 GFAP Results (I) – With no glutamate added the GAPDH normalized GFAP expression 
with and without the 7 waveforms of ES are shown in Figure 11.  The cathodic monophasic 
waveform results in a decrease by approximately 15% in the normalized expression level of this 
gene relative to the no ES control normalized expression levels. All other groups fall within the 
mean and standard deviation of the control groups. 
 
Figure 11: Comparison of GFAP normalized gene expression with the 7 ES waveforms to 
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GFAP Results (II) – The normalized GFAP expression in the presence of added 
glutamate is shown in Figure 12.  When added glutamate is present, the asymmetric biphasic 2-1 
and cathodic PR waveforms result in increases by approximately 110% and 60%, respectively, in 
the normalized expression level of this gene relative to the normalized expression level of the no 
ES control. All other groups fall within the mean and standard deviation of the control groups. 
 
Figure 12: Comparison of GFAP normalized gene expression with the 7 ES waveforms 
and glutamate to the GFAP normalized gene expression with only glutamate. Values are mean ± 
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 GFAP Results (III) – The normalized GFAP expression with and without added 
glutamate in the presence of the 7 waveforms of ES is shown in Figure 13.  The asymmetric 
biphasic 2-1 and cathodic PR waveforms, in the presence of added glutamate, result in increases 
by approximately 180% and 130% respectively in the normalized expression level of this gene 
relative to the no ES control groups’ normalized expression levels. This indicates that ES did not 
return the levels of expression, increased by glutamate, for this gene to control levels.  It suggests 
that the ES enhanced the increase in GFAP gene expression due to glutamate. All other groups 
fall within the mean and standard deviation of the control groups. 
 
Figure 13: Comparison of GFAP normalized gene expression with the 7 ES waveforms 
and the 7 ES waveforms with glutamate to the GFAP normalized gene expression control groups 
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GS Results (I) – With no glutamate added the GAPDH normalized GS expression with 
and without the 7 waveforms of ES are shown in Figure 14.    The anodic PR waveform results 
in an increase by approximately 15% in the normalized expression level of this gene relative to 
the no ES control normalized expression levels. The cathodic monophasic waveform results in a 
decrease by approximately 20% in the normalized expression level of this gene relative to the no 
ES control normalized expression levels. All other groups fall within the mean and standard 
deviation of the control groups.  
 
 
Figure 14: Comparison of GS normalized gene expression with the 7 ES waveforms to 
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GS Results (II) – The normalized GS expression in the presence of added glutamate is 
shown in Figure 15.  When added glutamate is present, the anodic PR waveform results in an 
increase by approximately 100% in the normalized expression level of this gene relative to the 
normalized expression level of the no ES control. Normalized expression levels for anodic 
monophasic and cathodic PR waveforms are very near the cut-off, however, the standard 
deviations fall within the control region. All other groups fall within the mean and standard 
deviation of the control groups.   
 
Figure 15: Comparison of GS normalized gene expression with the 7 ES waveforms and 
glutamate to the GS normalized gene expression with only glutamate. Values are mean ± SD for 
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 GS Results (III) – The normalized GS expression with and without added glutamate in the 
presence of the 7 waveforms of ES is shown in Figure 16.  The anodic PR waveform, in the 
absence or presence of added glutamate, result in increases by approximately 20% and 90%, 
respectively, in the normalized expression level of this gene relative to the no ES control groups’ 
normalized expression levels. The cathodic monophasic waveform, in the absence of added 
glutamate, results in a decrease by approximately 5% in the normalized expression level of this 
gene relative to the no ES control groups’ normalized expression levels. All other groups fall 
within the mean and standard deviation of the control groups.  
 
Figure 16: Comparison of GS normalized gene expression with the 7 ES waveforms and 
the 7 ES waveforms with glutamate to the GS normalized gene expression control groups 
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 GSR Results (I) –With no glutamate added the GAPDH normalized GSR expression with 
and without the 7 waveforms of ES are shown in Figure 17.  The cathodic monophasic waveform 
resulted in a decrease of approximately 15% in the normalized expression level of this gene 
relative to the no ES control normalized expression levels. All other groups fall within the mean 
and standard deviation of the control groups.  
 
Figure 17: Comparison of GSR normalized gene expression with the 7 ES waveforms to 
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GSR Results (II) – The normalized GSR expression in the presence of added glutamate is 
shown in Figure 18.  When added glutamate is present, the anodic PR and asymmetric biphasic 
2-1 waveforms result in increases by approximately 60% and 30%, respectively, in the 
normalized expression level of this gene relative to the normalized expression level of the no ES 
control. All other groups fall within the mean and standard deviation of the control groups.  
 
Figure 18: Comparison of GSR normalized gene expression with the 7 ES waveforms 
and glutamate to the GSR normalized gene expression with only glutamate. Values are mean ± 
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 GSR Results (III) – The normalized GSR expression with and without added glutamate in 
the presence of the 7 waveforms of ES is shown in Figure 19.  The anodic PR waveform, in the 
presence of added glutamate, results in an increase by approximately 30% in the normalized 
expression level of this gene relative to the no ES control groups’ normalized expression levels.  
This implies that ES helps cells respond to glutamate stress by increasing expression of this gene.  
All other groups fall within the mean and standard deviation of the control groups.  
 
Figure 19: Comparison of GSR normalized gene expression with the 7 ES waveforms 
and the 7 ES waveforms with glutamate to the GSR normalized gene expression control groups 
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 HMOX1 Results (I) – With no glutamate added the GAPDH normalized HMOX1 
expression with and without the 7 waveforms of ES are shown in Figure 20.  The anodic PR 
waveform results in an increase of approximately 30% in the normalized expression level of this 
gene relative to the no ES control normalized expression levels.  The symmetric biphasic 
waveform results in a decrease of approximately 10% in the normalized expression level of this 
gene relative to the no ES control normalized expression levels.  Normalized expression levels 
for cathodic monophasic and asymmetric biphasic 2-1 waveforms are very near the cut-off, 
however, the standard deviations fall within the control region.  All other groups fall within the 
mean and standard deviation of the control groups.   
 
Figure 20: Comparison of HMOX1 normalized gene expression with the 7 ES waveforms 
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HMOX1 Results (II) – The normalized HMOX1 expression in the presence of added 
glutamate is shown in Figure 21.  When added glutamate is present, the anodic PR waveform 
results in an increase by approximately 170% in the normalized expression level of this gene 
relative to the normalized expression level of the no ES control. All other groups fall within the 
mean and standard deviation of the control groups. 
 
Figure 21: Comparison of HMOX1 normalized gene expression with the 7 ES waveforms 
and glutamate to the HMOX1 normalized gene expression with only glutamate. Values are mean 
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HMOX1 Results (III) – The normalized HMOX1 expression with and without added 
glutamate in the presence of the 7 waveforms of ES is shown in Figure 22.  The anodic PR 
waveform, in the presence of added glutamate, results in an increase by approximately 170% in 
the normalized expression level of this gene relative to the no ES control groups’ normalized 
expression levels. The symmetric biphasic waveform, in the absence of added glutamate, results 
in a decrease by approximately 5% in the normalized expression level of this gene relative to the 
no ES control groups’ normalized expression levels. All other groups fall within the mean and 
standard deviation of the control groups. 
 
Figure 22: Comparison of HMOX1 normalized gene expression with the 7 ES waveforms 
and the 7 ES waveforms with glutamate to the HMOX1 normalized gene expression control 
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 MT2A Results (I) – With no glutamate added the GAPDH normalized MT2A expression 
with and without the 7 waveforms of ES are shown in Figure 23.   Normalized expression levels 
for symmetric biphasic waveform is very near the cut-off, however, the standard deviation falls 
within the control region.  All other groups fall within the mean and standard deviation of the 
control groups. 
 
Figure 23: Comparison of MT2A normalized gene expression with the 7 ES waveforms 
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MT2A Results (II) – The normalized MT2A expression in the presence of added 
glutamate is shown in Figure 24.  All groups fall within the mean and standard deviation of the 
control groups.  
 
Figure 24: Comparison of MT2A normalized gene expression with the 7 ES waveforms 
and glutamate to the MT2A normalized gene expression with only glutamate. Values are mean ± 
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MT2A Results (III) – The normalized MT2A expression with and without added 
glutamate in the presence of the 7 waveforms of ES is shown in Figure 25.  All groups fall within 
the mean and standard deviation of the control groups. 
 
Figure 25: Comparison of MT2A normalized gene expression with the 7 ES waveforms 
and the 7 ES waveforms with glutamate to the MT2A normalized gene expression control groups 
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S100A4 Results (I) – With no glutamate added the GAPDH normalized S100A4 
expression with and without the 7 waveforms of ES are shown in Figure 26.  The anodic PR 
waveform results in an increase by approximately 40% in the normalized expression level of this 
gene relative to the no ES control normalized expression levels.  The cathodic monophasic and 
anodic monophasic waveforms result in decreases of 20% and 10%, respectively, in the 
normalized expression level of this gene relative to the no ES control normalized expression 
levels.  Normalized expression levels for the asymmetric biphasic 1-2 waveform is very near the 
cut-off, however, the standard deviations fall within the control region.  All other groups fall 
within the mean and standard deviation of the control groups. 
 
Figure 26: Comparison of S100A4 normalized gene expression with the 7 ES waveforms 
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S100A4 Results (II) – The normalized S100A4 expression in the presence of added 
glutamate is shown in Figure 27.  When added glutamate is present, the anodic PR waveform 
results in an increase by approximately 40% in the normalized expression level of this gene 
relative to the normalized expression level of the no ES control. All other groups fall within the 
mean and standard deviation of the control groups. 
 
Figure 27: Comparison of S100A4 normalized gene expression with the 7 ES waveforms 
and glutamate to the S100A4 normalized gene expression with only glutamate. Values are mean 
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S100A4 Results (III) – The normalized S100A4 expression with and without added 
glutamate in the presence of the 7 waveforms of ES is shown in Figure 28.  The anodic PR 
waveform, in the absence of added glutamate, results in an increase by approximately 40% in the 
normalized expression level of this gene relative to the no ES control groups’ normalized 
expression levels.  All other groups fall within the mean and standard deviation of the control 
groups. 
 
Figure 28: Comparison of S100A4 normalized gene expression with the 7 ES waveforms 
and the 7 ES waveforms with glutamate to the S100A4 normalized gene expression control 
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SLC7A11 Results (I) – With no glutamate added the GAPDH normalized SLC7A11 
expression with and without the 7 waveforms of ES are shown in Figure 29.  The anodic PR 
waveform resulted in an increase by approximately 40% in the normalized expression level of 
this gene relative to the no ES control normalized expression levels.  The cathodic monophasic 
waveform results in a decrease by approximately 30% in the normalized expression level of this 
gene relative to the no ES control normalized expression levels.  All other groups fall within the 
mean and standard deviation of the control groups. 
 
Figure 29: Comparison of SLC7A11 normalized gene expression with the 7 ES 
waveforms to the SLC7A11 normalized gene expression without ES. Values are mean ± SD for 
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SLC7A11 Results (II) – The normalized SLC7A11 expression in the presence of added 
glutamate is shown in Figure 30.  All groups fall within the mean and standard deviation of the 
control groups. 
 
Figure 30: Comparison of SLC7A11 normalized gene expression with the 7 ES 
waveforms and glutamate to the SLC7A11 normalized gene expression with only glutamate. 
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SLC7A11 Results (III) – The normalized SLC7A11 expression with and without added 
glutamate in the presence of the 7 waveforms of ES is shown in Figure 31. The cathodic 
monophasic waveform, in the absence of added glutamate, results in a decrease by 
approximately 10% in the normalized expression level of this gene relative to the no ES control 
groups’ normalized expression levels. All other groups fall within the mean and standard 
deviation of the control groups.   
 
Figure 31: Comparison of SLC7A11 normalized gene expression with the 7 ES 
waveforms and the 7 ES waveforms with glutamate to the SLC7A11 normalized gene expression 
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QPCR Results Summary – The relative changes in gene expression results are 
summarized in Tables 2 and 3.  Using the conservative exclusionary criteria, the anodic PR 
waveform was found to have the most increases in relative gene expression with 15.  The 
cathodic monophasic was found to have the most decreases in relative gene expression with 7.  
Interestingly, this waveform was only modulating gene expression in the absence of glutamate.  
Asymmetric Biphasic 1-2 had no changes in relative gene expression lying outside the 
exclusionary regions.  All other ES waveforms were found to have modulated one or more genes 
sufficiently so as to satisfy the exclusionary criteria. Two of the clinically relevant waveforms, 
cathodic monophasic and symmetric biphasic are found to only down regulate gene expression 
and show no changes in the presence of added glutamate. The MT2A and SLC7A11 show the 
fewest changes in relative gene expression; however, the exclusionary regions on these graphs 
encompass a very wide range. By eye, there appear to be major changes in relative gene 
expression that are obscured by the conservative comparisons especially in the presence of 
glutamate. The most interesting gene in the study was GS because expression of this gene is 
predicted to be elevated upon addition of glutamate.  This was not observed in the presence of 
ES of various waveforms.   
In general, 7 of the 8 genes tested exhibited changes in gene expression related to 
application of ES with and without 10 mM glutamate added, in this study, relative to control 
cells. Since these 8 genes were selected due to the potential roles in cell responses to oxidative 







Table 2: Tabulated summary of the QPCR results. Bolded arrows (↑) are ES treatment groups. Non-bolded arrows (↑) are ES 
and glutamate treatment groups. The direction of the arrow indicates an increase or decrease. Roman numerals indicate graph type the 





ES BAG3 GFAP GS GSR HMOX1 MT2A S100A4 SLC7A11 # of 
Genes 
Affected 
 I II III I II III I II III I II III I II III I II III I II III I II III  
Cathodic − − − ↓ − − ↓ − ↓ ↓ − − − − − − − − ↓ − − ↓ − ↓ 5 
Anodic − ↑ ↑ − − − − − − − − − − − − − − − ↓ − − − − − 2 
SymBi − − − − − − − − − − − − ↓ − ↓ − − − − − − − − − 1 
AsymBi 
2-1 
− − − − ↑ ↑ − − − − ↑ − − − − − − − − − − − − − 2 
AsymBi 
1-2 
− − − − − − − − − − − − − − − − − − − − − − − − 0 
Cathodic 
PR 
− − − − ↑ ↑ − − − − − − − − − − − − − − − − − − 1 
Anodic 
PR 






Table 3: A) Tabulated summary of the effect of each waveform on the gene panel as a whole. B) Tabulated summary of the 
modulation of the gene panel tested.  
 
 
A Cathodic Anodic SymBi AsymBi 2-1 AsymBi 1-2 Cathodic PR Anodic PR 
Up Regulation 0 3 0 3 0 2 15 
Down Regulation 7 3 2 0 0 0 0 
B BAG3 GFAP GS GSR HMOX1 MT2A S100A4 SLC7A11 
Up Regulation 4 4 4 3 3 0 3 1 




Fluorescent Probe Assay Results – The results from the QPCR suggest that there is a 
perturbation of the transcribed RNA levels of some genes involved with intracellular processes 
involved with oxidative stress upon application of electrical stimulation.  There are also reports 
in the literature (Salvemini et al., 2011) suggesting an important connection between ROS and 
RNS and chronic pain. To establish whether or not electrical stimulation can effect ROS and 
RNS levels in the glioma cells, experiments to monitor the fluorescence signals of two molecular 
probes, sensitive to either superoxide radicals or nitric oxide radicals, were designed.  By 
introducing the same experimental conditions as the QPCR, effects on ROS and RNS probe 
signals in response to glutamate addition and/or electrical stimulation application were 
anticipated. The probe signals were measured at various times typically over the course of 2 
hours or more following ES and/or glutamate addition. Data are normalized relative to no 
treatment (control) cells which are set at 1.0 on the y-axis.  Polynomial trend lines of best fit 
were generated in Microsoft Excel to describe the trends in the signals. Also shown are the 
comparisons of the first time measurement as a function of ± glutamate ± ES relative to control 












Cathodic Passive Recharge – The DAF-FM signal following the cathodic PR waveform 
treatment is depicted in Figure 32(A,B). Initially the NO· probe signal for all the experimental 
groups is lower than the control cells without ES or glutamate (Figure 32A).  After 2 hours of 
incubation this changes and the experimental groups’ probe signals all exceed the signal of the 
control cells (Figure 32B). After 4 hours of incubation the combination of glutamate and ES 
show a 5% greater signal, but not significantly so, than either treatment alone. These results 
suggest that the NO· levels of the glioma cells is increased after administration of cathodic PR 
ES with or without glutamate.   
 
Figure 32 (A): Graphical representation of the normalized DAF-FM signal at the initial 
reading as a result of cathodic PR ES with or without glutamate treatment. Values are mean ± SD 











































Figure 32 (B): Graphical representation of the normalized DAF-FM signal changing with 
time as a result of cathodic PR ES with or without glutamate treatment. Values are mean ± SD of 
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Cathodic Passive Recharge cont. – The Mitosox Red Superoxide probe signal following 
cathodic PR waveform treatment is depicted in Figure 33(A,B). The cathodic PR stimulation 
Mitosox probe signal resulted in a decreased signal, of approximately 18% relative to the control 
cell signal at the first time point (Figure 33A). Both the added glutamate treatment and ES with 
added glutamate treatment resulted in higher Mitosox signals than the ES alone, but were still 
below the signal of the control cells (Figure 34B).  
 
Figure 33 (A): Graphical representation of the normalized Mitosox signal at the initial 
reading as a result of cathodic PR ES with or without glutamate treatment. Values are mean ± SD 














































Figure 33 (B): Graphical representation of the normalized Mitosox signal changing with 
time as a result of cathodic PR ES with or without glutamate treatment. Values are mean ± SD of 
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Anodic Passive Recharge Results – The DAF-FM signal following anodic PR waveform 
treatment is depicted in Figure 34(A,B). The effect of anodic PR ES on the DAF-FM signal is 
negligible relative to the no treatment control cells.  Introduction of glutamate causes the signal 
of DAF-FM to increase by approximately 30% relative to the no treatment control.  When the 
two treatments are combined glutamate increases the DAF-FM signal initially by about 15%, 
but, over time, the anodic PR ES lowers the probe signal down to nearly that of the no treatment 
control cells (Figure 34A,B).  This pattern suggests that glutamate increases the production of 
NO· and anodic PR ES is decreasing this effect of glutamate on the glioma cells. Also the anodic 
PR ES does not greatly impact NO· levels when glutamate levels are not elevated. 
 
Figure 34 (A): Graphical representation of the normalized DAF-FM signal at the initial 
reading as a result of anodic PR ES with or without glutamate treatment. Values are mean ± SD 










































Figure 34 (B): Graphical representation of the normalized DAF-FM signal changing with 
time as a result of anodic PR ES with or without glutamate treatment. Values are mean ± SD of 
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Anodic Passive Recharge Results cont. – The Mitosox Red Superoxide probe signal 
following anodic PR waveform treatment is depicted in Figure 35(A,B). There were no 
discernable trends in the Mitosox Red signal in response to anodic PR stimulation. Large 
fluctuations in the Mitosox Red signal, at this time, are likely due to an improper ratio of probe 
to cell count. 
 
Figure 35 (A): Graphical representation of the normalized Mitosox signal at the initial 
reading as a result of anodic PR ES with or without glutamate treatment. Values are mean ± SD 












































Figure 35 (B): Graphical representation of the normalized Mitosox signal changing with 
time as a result of anodic PR ES with or without glutamate treatment. Values are mean ± SD of 
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Time After Mitosox Addition (mins)
Mitosox Signal Normalized to Control Cells vs Minutes Post 
Anodic PR Stimulation




Cathodic Monophasic Results – The DAF-FM signal following cathodic monophasic 
waveform treatment is depicted in Figure 36(A,B). Initially all treatment groups showed an 
increase in the DAF-FM probe signal relative to the no treatment control (Figure 36A).  After 
two hours the signals for the glutamate treatment group and the glutamate and ES treatment 
group were trending down toward the no treatment control DAF-FM signal.  The ES treatment 
group DAF-FM signal was trending up relative to the no treatment control.  Further incubation 
shows that the cathodic monophasic treatment group DAF-FM signal continues to trend upward.  
The glutamate treatment group DAF-FM signal continues to trend down.  Interestingly, the 
glutamate and ES treatment group trend inverted and began to trend upward as incubation time 
increased (Figure 36B).  These data suggest cathodic monophasic ES results in increases in the 








Figure 36 (A): Graphical representation of the normalized DAF-FM signal at the initial 
reading as a result of cathodic monophasic ES with or without glutamate treatment. Values are 



















































Figure 36 (B): Graphical representation of the normalized DAF-FM signal changing with 
time as a result of cathodic monophasic ES with or without glutamate treatment. Values are 
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Time After DAF-FM Addition (mins)
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Cathodic Monophasic Stimulation




Cathodic Monophasic Results cont. – The Mitosox Red Superoxide probe signal 
following cathodic monophasic waveform treatment is depicted in Figure 37(A,B). Only the ES 
treatment group signal appears to have increased relative to control cells at the first time point 
(Figure 37A). The cathodic monophasic electrical stimulation group Mitosox signal is trending 
down as incubation progresses suggesting the ES treatment utilizing cathodic monophasic 
stimulation results in decreasing the production of superoxide.  The glutamate treatment showed 
a slight decrease in the Mitosox signal relative to the no treatment control group.  This trend in 
the Mitosox signal is stable over the course of the incubation period. Treatment with both ES and 
glutamate shows very little deviation from the Mitosox signal of the no treatment control (Figure 
37B).    
Figure 37 (A): Graphical representation of the normalized Mitosox signal at the initial 
reading as a result of cathodic monophasic ES with or without glutamate treatment. Values are 










































Figure 37 (B): Graphical representation of the normalized Mitosox signal changing with 
time as a result of cathodic monophasic ES with or without glutamate treatment. Values are 
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Time After Mitosox Addition (mins)
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Cathodic Monophasic Stimulation




Anodic Monophasic Results – The DAF-FM signal following anodic monophasic 
waveform treatment is depicted in Figure 38(A,B). The ES treatment group DAF-FM signal 
shows very little deviation from the probe signal of the no treatment control.  The glutamate 
treatment group DAF-FM signal was increased relative to the signal of the no treatment control.  
Treating the glioma cells with both ES and glutamate shows a marked increase in the DAF-FM 
signal relative to the no treatment control.  These results suggest that the anodic monophasic 
waveform may be inducing the production of NO· when the cells are exposed to glutamate.   
 
Figure 38 (A): Graphical representation of the normalized DAF-FM signal at the initial 
reading as a result of anodic monophasic ES with or without glutamate treatment. Values are 












































Figure 38 (B): Graphical representation of the normalized DAF-FM signal changing with 
time as a result of anodic monophasic ES with or without glutamate treatment. Values are mean 
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Time After DAF-FM Addition (mins)
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Anodic Monophasic Results cont. – The Mitosox Red Superoxide probe signal following 
anodic monophasic waveform treatment is depicted in Figure 39(A,B). All treatment groups 
resulted in Mitosox signals that are decreased relative to the no treatment control. There were no 
other discernable trends in the Mitosox Red signal in response to anodic monophasic stimulation. 
Large fluctuations in the Mitosox Red signal, at this time, are likely due to an improper ratio of 
probe to cell count. 
 
Figure 39 (A): Graphical representation of the normalized Mitosox signal at the initial 
reading as a result of anodic monophasic ES with or without glutamate treatment. Values are 










































Figure 39 (B): Graphical representation of the normalized Mitosox signal changing with 
time as a result of anodic monophasic ES with or without glutamate treatment. Values are mean 
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Time After Mitosox Addition (mins)
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Anodic Monophasic Stimulation




Asymmetric Biphasic 1-2 Results – The DAF-FM signal following asymmetric biphasic 
1-2 waveform treatment is depicted in Figure 40(A,B). Treatment with glutamate and ES or ES 
alone resulted in an increase in the DAF-FM signal, relative to the no treatment control, as 
incubation progressed.  The glutamate treatment alone shows a downward trend as incubation 
progressed (Figure 40B).  These results indicate that asymmetric biphasic 1-2 ES can elevate 
NO· levels independent of added glutamate.   
 
Figure 40 (A): Graphical representation of the normalized DAF-FM signal at the initial 
reading as a result of asymmetric biphasic 1-2 ES with or without glutamate treatment. Values 











































Figure 40 (B): Graphical representation of the normalized DAF-FM signal changing with 
time as a result of asymmetric biphasic 1-2 ES with or without glutamate treatment. Values are 
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Time After DAF-FM Addition (mins)
DAF-FM Signal Normalized to Control Cells vs Minutes Post 
Asymmetric Biphasic 1-2 Stimulation




Asymmetric Biphasic 1-2 Results cont. – The Mitosox Red Superoxide probe signal 
following asymmetric biphasic 1-2 waveform treatment is depicted in Figure 41(A,B). There 
were no discernable trends in the Mitosox Red signal in response to asymmetric biphasic 1-2 
stimulation. Large fluctuations in the Mitosox Red signal, at this time, are likely due to an 
improper ratio of probe to cell count.  
 
Figure 41 (A): Graphical representation of the normalized Mitosox signal at the initial 
reading as a result of asymmetric biphasic 1-2 ES with or without glutamate treatment. Values 












































Figure 41 (B): Graphical representation of the normalized Mitosox signal changing with 
time as a result of asymmetric biphasic 1-2 ES with or without glutamate treatment. Values are 
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Mitosox Signal Normalized to Control Cells vs Minutes Post 
Asymmetric Biphasic 1-2 Stimulation




 Asymmetric Biphasic 2-1 Results – The DAF-FM signal following asymmetric biphasic 
2-1 waveform treatment is depicted in Figure 42(A,B). The ES treatment group initially shows a 
DAF-FM signal that is lower than the no treatment control (Figure 42A), and trended downward 
as the incubation progressed.  The glutamate treatment group initially shows a DAF-FM signal 
that is higher than the no treatment control, but trended downward as the incubation progressed.  
The treatment group with both ES and glutamate begins moderately higher than the no treatment 
control, and trended downward as incubation progressed (Figure 42B).  These results indicate 
that NO· levels in the glioma cells are elevated in response to glutamate and reduced in upon 
application of asymmetric biphasic 2-1 stimulation. 
 
Figure 42 (A): Graphical representation of the normalized DAF-FM signal at the initial 
reading as a result of asymmetric biphasic 2-1 ES with or without glutamate treatment. Values 








































Figure 42 (B): Graphical representation of the normalized DAF-FM signal changing with 
time as a result of asymmetric biphasic 2-1 ES with or without glutamate treatment. Values are 
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Asymmetric Biphasic 2-1 Stimulation




 Asymmetric Biphasic 2-1 Results cont. – The Mitosox Red Superoxide probe signal 
following asymmetric biphasic 2-1 waveform treatment is depicted in Figure 43(A,B). There 
were no discernable trends in the Mitosox Red signal in response to asymmetric biphasic 2-1 
stimulation. Large fluctuations in the Mitosox Red signal, at this time, are likely due to an 
improper ratio of probe to cell count. 
 
Figure 43 (A): Graphical representation of the normalized Mitosox signal at the initial 
reading as a result of asymmetric biphasic 2-1 ES with or without glutamate treatment. Values 











































Figure 43 (B): Graphical representation of the normalized Mitosox signal changing with 
time as a result of asymmetric biphasic 2-1 ES with or without glutamate treatment. Values are 
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Time After Mitosox Addition (mins)
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Asymmetric Biphasic 2-1 Stimulation




 Symmetric Biphasic Results – The DAF-FM signal following symmetric biphasic 
waveform treatment is depicted in Figure 44(A,B). Treatment with ES increased the DAF-FM 
signal by approximately 15% relative to the no treatment control (Figure 44A).  The group that 
received the glutamate treatment shows an even greater increase in the signal of DAF-FM 
relative to the no treatment control cells.  Treatment with both glutamate and symmetric biphasic 
ES shows an elevated DAF-FM signal, relative to the no treatment control cells, that falls 
between the other two groups (Figure 44B).  These results indicate that symmetric biphasic 
stimulation does not have a large impact on the level of NO· in comparison to when added 
glutamate is present.   
 
Figure 44 (A): Graphical representation of the normalized DAF-FM signal at the initial 
reading as a result of symmetric biphasic ES with or without glutamate treatment. Values are 








































Figure 44 (B): Graphical representation of the normalized DAF-FM signal changing with 
time as a result of symmetric biphasic ES with or without glutamate treatment. Values are mean 
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Time After DAF-FM Addition (mins)
DAF-FM Signal Normalized to Control Cells vs Minutes Post 
Symmetric Biphasic Stimulation




Symmetric Biphasic Results cont. – The Mitosox Red Superoxide probe signal for the 
symmetric biphasic waveform is depicted in Figure 45(A,B). Although there is a large degree of 
noise in the Mitosox signal, the ES and ES with added glutamate treatment groups are trending 
up in concert relative to the no treatment control group as incubation progresses (Figure 45B). 
This result may be indicating an effect of symmetric biphasic ES on increasing the level of 
superoxide radicals in the glioma cells.  The glutamate treatment group has a consistently lower 
Mitosox signal than the no treatment control cells.  The large fluctuations in the Mitosox signals 
in all the treatment groups prevent this from being a defendable conclusion at the first time point, 
but last one shows this trend clearly. 
 
Figure 45 (A): Graphical representation of the normalized Mitosox signal at the initial 
reading as a result of symmetric biphasic ES with or without glutamate treatment. Values are 








































Figure 45 (B): Graphical representation of the normalized Mitosox signal changing with 
time as a result of symmetric biphasic ES with or without glutamate treatment. Values are mean 
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 Fluorescent Probe Assay Summary – The trends in the fluorescent probe signals 
measured are summarized in Tables 4 and 5. In Table 4 the arrows indicate increases or 
decreases in probe signal (at the first time point) relative to control cells for all waveforms used.  
For six of the seven waveforms there is an increase in signal with added glutamate treatment as 
well as ES with added glutamate treatment. The ES treatment alone shows mixed results at the 
first time point. In Table 5 arrows are indicating the direction of the trend between the first and 
last time points. The two asymmetric biphasic waveforms result in trends that are almost mirror 
images of one another. Cathodic PR ES, one of the clinically relevant waveforms, results in 
increasing trends for the DAF-FM probe, but a steady or decreasing signal for the Mitosox 
probe. Anodic PR ES, the most impactful waveform on the genes tested in the QPCR 
experiments, results in opposing trends for the two probes with added glutamate. Cathodic 
monophasic results in opposing trends for the two probes in the absence of added glutamate. 
Anodic monophasic results in an increase in the trend of the DAF-FM probe in the presence of 
added glutamate.  Symmetric biphasic ES results in an increase in the trend of the Mitosox probe 












Table 4: Tabulated summary of the fluorescent probe trend results at the first time point. 
Arrows (↑) indicate the direction of the change in signal relative to the signal of the normalized 
control cells. Hyphens (−) indicate no change in signal relative to the signal of the normalized 
control cells. 
 
Table 5: Tabulated summary of the fluorescent probe trend results. Bolded arrows (↑) 
indicate the direction of the change in trend of the normalized probe signal over the course of the 
experiment. Hyphens (−) indicate a normalized probe signal that was stable with time over the 
course of the experiment. 
  
DAF-FM Signal 
Waveform ES Glu Glu + ES 
Cathodic ↑ ↑ ↑ 
Anodic − ↑ ↑ 
SymBi ↑ ↑ ↑ 
AsymBi 2-1 ↓ ↑ ↑ 
AsymBi 1-2 ↑ ↑ ↑ 
Cathodic PR ↓ ↓ ↓ 











  Waveform ES Glu 
ES and 
Glu ES Glu 
ES and 
Glu 
Cathodic ↑ ↓ ↑ ↓ − − 4 
Anodic − − ↑ − − − 1 
SymBi − − − ↑ − ↑ 2 
AsymBi 
2-1 ↓ ↓ ↓ − ↓ ↓ 5 
AsymBi 
1-2 ↑ ↓ ↑ − ↑ ↑ 5 
Cathodic 
PR ↑ ↑ ↑ − ↓ − 4 
Anodic 




CHAPTER IV: CONCLUSION 
Conclusions – Glial cells, a primary component of the central nervous system, have a 
diverse set of functions.  Recently, cells of this type have been implicated in the development of 
chronic pain in animal model systems (Vallejo et al., 2016).  The progression of this pathology is 
poorly understood, but there is evidence that oxidative stress, pertaining to reactive oxygen and 
reactive nitrogen species, is intimately involved.  To treat chronic neuropathic pain in the clinic, 
medical professionals utilize many treatment strategies, including electrical stimulation.  From a 
mechanistic stand point, the effectiveness of ES treatments are in need of description.  With the 
goal of developing a non-animal model system to test the mechanism(s) of action of the 
electrical stimulation treatments, experiments were designed to test electrically stimulated cells 
in culture for changes in gene expression, ROS, and RNS. 
As evidenced by the tabulated summaries, the changes measured in gene expression and 
ROS and RNS levels varied widely.  There are a couple of trends that seem promising, however.  
The anodic PR waveform was especially interesting since six of the eight genes tested showed 
increases in expression levels relative to the control groups, even with the conservative criteria 
used here.  Additionally, the NO· probe experiment suggest this waveform may be counter-acting 
the effect of glutamate on the glioma cells’ RNS levels. The cathodic monophasic waveform 
elicited an effect on five of the eight genes tested in the QPCR analysis and was consistent in 
decreasing the expression levels. The fluorescent probe studies for cathodic monophasic also 
gave intriguing results where the NO· probe trends inverted in response to glutamate and 
cathodic monophasic stimulation as incubation times increased. Anodic monophasic and 
asymmetric biphasic 2-1 showed changes in two of eight genes tested, but not in the same two 




Asymmetric biphasic 1-2 showed no change in normalized gene expression for any of the eight 
genes tested. Yet all waveforms result in one or more relative changes in ROS or RNS signals. 
 It is worth noting that exclusion criteria for the gene expression study were intentionally 
broad, encompassing the mean and standard deviation of all the control groups for all the 
waveforms.  This was done to account for the plate to plate variability introduced by the 
differences in the cell population that were potentially changing over time.  As a result of this, 
there were a number experimental conditions that were very near the cut-off region. These sets of 
conditions may lead to significant changes in gene expression, but are obscured by our 
conservative criteria leaving only some changes in expression to be considered as significant. 
 The most significant conclusion to be drawn from these results is that the glioma cell 
culture method developed in this thesis is capable of monitoring differential gene expression and 
perturbations in ROS and RNS probe signals as a result of applied ES with or without glutamate.  
This glial cell model system can thus be utilized to investigate the effects of different waveforms 






CHAPTER V: FUTURE WORK 
Mitosox Optimization – During the course of the experiments the fluorescence signal of 
the Mitosox probe has shown a wide degree of variation.  At this time, this fluctuation is 
attributed to an improper concentration of Mitosox relative to the population of glioma cells.  To 
improve signal of this probe an optimization experiment should be conducted using a serial 
dilution of Mitosox.     
Temperature Effects Experiment – The effect of temperature was poorly controlled 
during the course of our ES experiments and remains a potential source of error that may be 
obscuring trends in the results.  The stimulation step of the experiments was performed at room 
temperature due to instrumental limitations.  To better account for the effect temperature has on 
this system, the fluorescent probe experiments should be conducted using a slide warmer 
apparatus to help maintain 37 °C during the stimulation step of the experiment.  If there is a large 
effect on ROS or RNS probe signals due to temperature fluctuations, this experiment may help to 
improve our controls on this system.  
Dimethylfumarate Experiment – A compound, dimethylfumarate (DMF), currently 
undergoing clinical trials for treatment of multiple sclerosis, is reported to elicit effects on ROS 
and RNS balance in the neurological system by acting as an enzyme inhibitor.  To test whether 
or not this compound is affecting the ROS and RNS balance of glial cells, and if ES is impactful 
on this process, DMF should also be tested as the cellular perturbant, in place of glutamate, in the 
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APPENDIX A: SUPPLIMENTRY MATERIALS 
Modified Dulbecco’s Modified Eagle’s Medium Formulation –  CaCl2 (anhydrous) – 0.2000 
g/L; Fe(NO3)3·9H2O – 0.0001 g/L; MgSO4 (anhydrous) – 0.09770 g/L; KCl – 0.4000 g/L; 
NaHCO3 – 1.5000 g/L; NaCl 6.4000 g/L; NaH2PO4·H2O – 0.1250 g/L; D-Glucose – 4.5000 g/L; 
Sodium Pyruvate – 0.1100 g/L. The pH was adjusted to 7.3 prior to filter sterilization.   
     
